MyFinsight
Home
Blog
About
Back
Income Statement
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)
source: myfinsight.com
Hypercortisolism Products
$208,583K
Lifyorli
$47,564K
Product revenue, net
$256,147K
(31.74%↑ Y/Y)
Income (loss) from
operations
$41,300K
(54.83%↑ Y/Y)
Interest and other income
$4,631K
(-7.69%↓ Y/Y)
Total operating
expenses
$214,847K
(28.07%↑ Y/Y)
Income before income
taxes
$45,931K
(44.93%↑ Y/Y)
Selling, general and
administrative
$156,896K
(51.08%↑ Y/Y)
Research and development
$53,890K
(-10.88%↓ Y/Y)
Cost of sales
$4,061K
(18.29%↑ Y/Y)
Net income
$42,987K
(22.30%↑ Y/Y)
Income tax (expense)
benefit
$2,944K
(185.16%↑ Y/Y)
Back